The first 3 groups of rats were administered with different concentrations of the pomegranate peel extract (500 [micro]g/mL, 250 [micro]g/mL, and 125 [micro]g/mL), the fourth group was administered with nystatin
(100000 U/kg/d), the fifth group was immunosuppressed and induced with oral candidiasis without treatment, the sixth group (control group) was not immunosuppressed and given only the pomegranate peel extract, and the seventh group was only immunosuppressed (table 1).
aureus (A) 1.25 10.4 [+ or -] 0.8 Methanol (a) 2.5 16.7 [+ or -] 1.2 5 21.3 [+ or -] 0.6 1.25 4.2 [+ or -] 0.5 Chloroform (b) 2.5 7.5 [+ or -] 0.9 5 12 [+ or -] 1.4 1.25 3.6 [+ or -] 1.1 Water (b) 2.5 7.1 [+ or -] 0.8 5 10.3 [+ or -] 1.5 Chloramphenicol 20 [+ or -] 0.5 Nystatin
Zone of inhibition (mm) Gram-positive Gram-negative Solvent bacteria bacteria extract B.
Subsequently, 100 [micro]g/mL of nystatin
was dispensed into the wells of the first row followed by microdilution, in order to obtain concentrations of 1,024 [micro]g/mL to 4 [micro]g/mL.
albicans isolates from diabetic patients were highly susceptible to amphotericin B, fluconazole and nystatin
(100%) while 100% of them were resistant to econazole and 75% were resistant to miconazole.
(500,000 units) when combined with tissue conditioner was effective against candida albicans and can be an effective treatment in non-compliant DIS patients.
fumigatus were subjected to in-vitro antifungal drug sensitivity against Amphotericin-B, Clotrimazole, Nystatin
A comparison of vaginal nystatin
and oral fluconazole for treating RVVC was performed in a recent study on 293 patients by a Chinese research group (23).
in denture liners--an alternative treatment of denture stomatitis.
Our patient had used nystatin
cream, which is effective against Candida yeast infections, but not especially effective for Malassezia sp.
Several authors have analyzed nystatin
's physical and chemical characteristics (MICHEL, 1972).
In 1990, Dismukes and coworkers published a study of nystatin
for candidiasis hypersensitivity syndrome.
Although it was patented back in .1957 as the world's first antifungal, antibiotic nystatin
upstaged newer antifungal agents when used to treat vulvovaginal candidiasis caused by Candida glabrata in sequential, prospective clinical trials.